Howard Benjamin
CIK 1393547 · View on SEC EDGAR ↗
Insider
First SEC filing: March 27, 2013 · Latest: March 27, 2013
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 49 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
49 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 14, 2017 | RGEN | S | 12,729 | $35.34 | $449,843 | 33,908 Direct | -27.29% | Disposed | 403.2% (price as of 2026-08-19) |
| March 20, 2017 | RGEN | S | 7,248 | $34.63 | $250,998 | 23,908 Direct | -23.26% | Disposed | 413.5% (price as of 2026-08-19) |
| March 20, 2017 | RGEN | S | 4,968 | $34.61 | $171,942 | 31,156 Direct | -13.75% | Disposed | 413.8% (price as of 2026-08-19) |
| May 11, 2016 | RGEN | S | 2,889 | $26.72 | $77,194 | 18,626 Direct | -13.43% | Disposed | 565.6% (price as of 2026-08-19) |
| June 9, 2015 | RGEN | S | 7,697 | $37.48 | $288,484 | 11,554 Direct | -39.98% | Disposed | 374.5% (price as of 2026-08-19) |
| June 8, 2015 | RGEN | S | 27,303 | $38.32 | $1,046,251 | 19,251 Direct | -58.65% | Disposed | 364.1% (price as of 2026-08-19) |
| March 18, 2015 | RGEN | S | 15,795 | $32.63 | $515,391 | 46,554 Direct | -25.33% | Disposed | 445.0% (price as of 2026-08-19) |
| Nov. 11, 2014 | RGEN | S | 30,000 | $23.56 | $706,800 | 43,851 Direct | -40.62% | Disposed | 654.8% (price as of 2026-08-19) |
| Aug. 13, 2014 | RGEN | S | 40,000 | $20.34 | $813,600 | 73,851 Direct | -35.13% | Disposed | 774.3% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 14, 2017 | RGEN | Stock Option (Right to Buy) | Common Stock (4,062) | $26.05 | Feb. 26, 2026 | 4,062 | Disposed |
| Dec. 14, 2017 | RGEN | Stock Option (Right to Buy) | Common Stock (6,021) | $26.20 | Feb. 26, 2025 | 6,021 | Disposed |
| Dec. 14, 2017 | RGEN | Stock Option (Right to Buy) | Common Stock (2,646) | $15.91 | Feb. 27, 2024 | 2,646 | Disposed |
| March 20, 2017 | RGEN | Stock Option (Right to Buy) | Common Stock (10,000) | $6.23 | Feb. 28, 2023 | 10,000 | Disposed |
| March 20, 2017 | RGEN | Stock Option (Right to Buy) | Common Stock (4,968) | $15.91 | Feb. 27, 2024 | 4,968 | Disposed |
| Feb. 23, 2017 | RGEN | Stock Option (Right to Buy) | Common Stock (8,289) | $32.40 | Feb. 23, 2027 | 8,289 | Acquired |
| Feb. 23, 2017 | RGEN | Stock Option (Right to Buy) | Common Stock (9,012) | $32.40 | Feb. 23, 2027 | 9,012 | Acquired |
| Feb. 23, 2017 | RGEN | Stock Option (Right to Buy) | Common Stock (9,012) | $32.32 | Feb. 23, 2027 | 9,012 | Acquired |
| May 24, 2016 | RGEN | Stock Option (Right to Buy) | Common Stock (10,000) | $6.23 | Feb. 28, 2023 | 10,000 | Disposed |
| Feb. 26, 2016 | RGEN | Stock Option (Right to Buy) | Common Stock (12,186) | $26.05 | Feb. 26, 2026 | 12,186 | Acquired |
| Nov. 19, 2015 | RGEN | Stock Option (Right to Buy) | Common Stock (5,000) | $3.33 | July 15, 2020 | 5,000 | Disposed |
| March 18, 2015 | RGEN | Stock Option (Right to Buy) | Common Stock (3,807) | $15.91 | Feb. 27, 2024 | 3,807 | Disposed |
| March 18, 2015 | RGEN | StockOption (Right to Buy) | Common Stock (10,000) | $6.23 | Feb. 28, 2023 | 10,000 | Disposed |
| Feb. 26, 2015 | RGEN | Stock Option (Right to Buy) | Common Stock (9,031) | $24.98 | Feb. 26, 2025 | 9,031 | Acquired |
| Aug. 13, 2014 | RGEN | Stock Option (Right to Buy) | Common Stock (5,000) | $3.33 | July 15, 2020 | 5,000 | Disposed |
| June 5, 2014 | RGEN | Stock Option (Right to Buy) | Common Stock (10,000) | — | Feb. 28, 2023 | 10,000 | Disposed |
| June 5, 2014 | RGEN | Stock Option (Right to Buy) | Common Stock (5,000) | — | July 15, 2020 | 5,000 | Disposed |
| June 5, 2014 | RGEN | Stock Option (Right to Buy) | Common Stock (87,036) | — | Feb. 11, 2019 | 87,036 | Disposed |
| Feb. 27, 2014 | RGEN | Stock Option (Right to Buy) | Common Stock (11,421) | $15.91 | Feb. 27, 2024 | 11,421 | Acquired |
| May 6, 2013 | RGEN | Stock Option (Right to Buy) | Common Stock (10,000) | — | July 15, 2020 | 10,000 | Disposed |
| May 6, 2013 | RGEN | Stock Option (Right to Buy) | Common Stock (12,964) | — | Feb. 11, 2019 | 12,964 | Disposed |
| Feb. 28, 2013 | RGEN | Stock Option (Right to Buy) | Common Stock (40,000) | $6.23 | Feb. 28, 2023 | 40,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 4 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2017 | $293,117 | — | — | — | $154,282 | — | $5,000 | $734,796 |
| 2016 | $287,000 | — | — | — | $122,994 | — | $2,000 | $739,493 |
| 2015 | $279,000 | — | — | — | $120,528 | — | $2,000 | $652,641 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.